UMIN-ICDS Clinical Trial
| Unique ID issued by UMIN | UMIN000060460 |
|---|---|
| Receipt number | R000069128 |
| Scientific Title | Study on the Efficacy of test product for Skin Tags on neck |
| Date of disclosure of the study information | 2026/02/01 |
| Last modified on | 2026/01/23 16:39:21 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Study on the Efficacy of test product for Skin Tags on neck
Acronym
Study on the Efficacy of test product for Skin Tags on neck
Scientific Title
Study on the Efficacy of test product for Skin Tags on neck
Scientific Title:Acronym
Study on the Efficacy of test product for Skin Tags on neck
Region
| Japan |
Condition
Condition
Healthy people
Classification by specialty
| Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
The purpose is to verify the efficacy of test product against skin tags on the neck.
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Skin tag area and Skin Tag Color
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Self control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Treatment
Type of intervention
| Other |
Interventions/Control_1
The test product will be applied once daily for three months to either the left or right side of the neck.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 30 | years-old | <= |
Age-upper limit
| 80 | years-old | > |
Gender
Male and Female
Key inclusion criteria
1) Japanese men and women aged 30 to 79 years old at the time of consent acquisition, with multiple small skin tags on the neck suitable for this study
2) No prior treatment administered to the study site
3) Able to attend designated examination appointments and complete required documentation
4) Received full explanation of the study's purpose and content, and provided written consent to participate of their own free will
Key exclusion criteria
1) allergic diseases or a history of drug allergy symptoms
2) exhibiting hypersensitivity reactions to the test substance
3) Pregnant,planning pregnancy during the study and breastfeeding women
4) unable to apply the test substance as instructed
5) participating in other clinical trials, studies, or research
6) unable to comply with the principal investigator's instructions, or those deemed unsuitable by the principal investigator
Target sample size
30
Research contact person
Name of lead principal investigator
| 1st name | Yukiko |
| Middle name | |
| Last name | Ishitsuka |
Organization
DHC Corporation
Division name
Fragrance and Cosmetics Unit
Zip code
108-0023
Address
2-7-1 Shibaura, Minato-ku, Tokyo
TEL
03-5765-9518
yshinmoto@dhc.co.jp
Public contact
Name of contact person
| 1st name | Junichiro |
| Middle name | |
| Last name | Nagumo |
Organization
DHC Corporation
Division name
Fragrance and Cosmetics Unit
Zip code
108-0023
Address
2-7-1 Shibaura, Minato-ku, Tokyo
TEL
03-5765-9518
Homepage URL
jnagumo@dhc.co.jp
Sponsor or person
Institute
DHC Corporation
Institute
Department
Personal name
Funding Source
Organization
DHC Corporation
Organization
Division
Category of Funding Organization
Profit organization
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
DHC Ethics Review Committee
Address
2-7-1, Minamiazabu, Minato-ku, Tokyo
Tel
N/A
ml-ethicsoffice@dhc.co.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2026 | Year | 02 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2025 | Year | 12 | Month | 24 | Day |
Date of IRB
Anticipated trial start date
| 2026 | Year | 02 | Month | 01 | Day |
Last follow-up date
| 2026 | Year | 06 | Month | 30 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2026 | Year | 01 | Month | 25 | Day |
Last modified on
| 2026 | Year | 01 | Month | 23 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000069128
